Header Logo

Connection

David Bennett to Epigenomics

This is a "connection" page, showing publications David Bennett has written about Epigenomics.
Connection Strength

1.110
  1. An inflection point in gene discovery efforts for neurodegenerative diseases: from syndromic diagnoses toward endophenotypes and the epigenome. JAMA Neurol. 2013 Jun; 70(6):719-26.
    View in: PubMed
    Score: 0.433
  2. The association of epigenetic clocks in brain tissue with brain pathologies and common aging phenotypes. Neurobiol Dis. 2021 09; 157:105428.
    View in: PubMed
    Score: 0.189
  3. EPIGENOMIC FEATURES RELATED TO MICROGLIA ARE ASSOCIATED WITH ATTENUATED EFFECT OF APOE e4 ON ALZHEIMER'S DISEASE RISK IN HUMANS. Alzheimers Dement. 2020 12; 16(Suppl 2).
    View in: PubMed
    Score: 0.182
  4. Bayesian integrative analysis of epigenomic and transcriptomic data identifies Alzheimer's disease candidate genes and networks. PLoS Comput Biol. 2020 04; 16(4):e1007771.
    View in: PubMed
    Score: 0.174
  5. Epigenomic features related to microglia are associated with attenuated effect of APOE e4 on Alzheimer's disease risk in humans. Alzheimers Dement. 2022 04; 18(4):688-699.
    View in: PubMed
    Score: 0.048
  6. A machine learning approach to brain epigenetic analysis reveals kinases associated with Alzheimer's disease. Nat Commun. 2021 07 22; 12(1):4472.
    View in: PubMed
    Score: 0.048
  7. An xQTL map integrates the genetic architecture of the human brain's transcriptome and epigenome. Nat Neurosci. 2017 Oct; 20(10):1418-1426.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.